COMT inhibitors for motor fluctuations in Parkinson’s disease

COMT inhibitors for motor fluctuations in Parkinson’s disease

COMPLETE Neurology Review for the USMLE Step 2 (with 200 Review Questions!!)Подробнее

COMPLETE Neurology Review for the USMLE Step 2 (with 200 Review Questions!!)

Adjunctive MAO-B or COMT inhibitors to optimize levodopa treatment in PDПодробнее

Adjunctive MAO-B or COMT inhibitors to optimize levodopa treatment in PD

LECIG for motor fluctuations in Parkinson's diseaseПодробнее

LECIG for motor fluctuations in Parkinson's disease

BIPARK-I and II: opicapone and levodopa in PD with motor fluctuationsПодробнее

BIPARK-I and II: opicapone and levodopa in PD with motor fluctuations

Design of the EPSILON trial of opicapone as an add-on to levodopa in early PDПодробнее

Design of the EPSILON trial of opicapone as an add-on to levodopa in early PD

COMT inhibitors for Parkinson’s disease: clinical updatesПодробнее

COMT inhibitors for Parkinson’s disease: clinical updates

Investigations into managing non-motor fluctuationsПодробнее

Investigations into managing non-motor fluctuations

Tips and Strategies in the Management of Motor Fluctuations in Parkinson's DiseaseПодробнее

Tips and Strategies in the Management of Motor Fluctuations in Parkinson's Disease

Management of Motor Fluctuations in Parkinson's Disease Webinar (Nov 29)Подробнее

Management of Motor Fluctuations in Parkinson's Disease Webinar (Nov 29)

Joaquim Ferreira, MDS 2019 – The time course of motor complications in Parkinson'sПодробнее

Joaquim Ferreira, MDS 2019 – The time course of motor complications in Parkinson's

Diagnosis and management of levodopa response fluctuations in Parkinson’s disease – Werner PoeweПодробнее

Diagnosis and management of levodopa response fluctuations in Parkinson’s disease – Werner Poewe

Parkinson's Medications - Part 3: Medication ManagementПодробнее

Parkinson's Medications - Part 3: Medication Management

Parkinson's Medications - Part 2: Dopamine Agonists, MAO-B Inhibitors, and MoreПодробнее

Parkinson's Medications - Part 2: Dopamine Agonists, MAO-B Inhibitors, and More

Recognition and management of wearing off utilisation of COMT inhibitors – Oliver RascolПодробнее

Recognition and management of wearing off utilisation of COMT inhibitors – Oliver Rascol

Repositioning COMT inhibitors and response duration in levodopa optimisation – round tableПодробнее

Repositioning COMT inhibitors and response duration in levodopa optimisation – round table